Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

iShares S&P 500 ETF

IVV

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

Vanguard MSCI Index International Shares ETF

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

CSL Limited

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

Woolworths Group Limited

WOW

Woolworths Group Ltd. engages in the operation of general merchandise consumer stores and supermarkets in Australia, New Zealand and India. The company is headquartered in Sydney, New South Wales and currently employs 201,000 full-time employees. The firm's segments include Australian Food, Australian B2B, New Zealand Food, BIG W and Other. The Australian Food segment is engaged in procurement of food, drinks and related products for resale and provision of services (including eCommerce) to retail and business customers in Australia. The Australian B2B segment includes procurement and distribution of food and related products for resale to other businesses and provision of supply chain services to business customers in Australia. The New Zealand Food segment includes procurement of food, drinks and related products for resale and provision of services (including eCommerce) to retail and wholesale customers in New Zealand. The BIG W segment includes procurement of discount general merchandise products for resale (including via eCommerce) to retail customers in Australia. The Other segment comprises Quantium and MyDeal as well as various support functions.